Point of Care Ultrasound for the Detection of Esophageal Food Bolus
NCT ID: NCT06507670
Last Updated: 2024-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2024-07-01
2027-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will otherwise receive medical treatment per standard of care. Subsequent interventions will also be documented, including glucagon, carbonated beverages, and esophagogastroduodenoscopy (EGD). If patients remain in the ED and improve without need for EGD they will undergo repeat ultrasound. Chart review at 1 month will be performed to establish results of EGD including improvement, recurrence, or presence of pathologic abnormalities. The investigators aim to establish normal and abnormal parameters to aid in the diagnosis of esophageal food impactions to predict need for definitive EGD management.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
POCUS for Small Bowel Obstruction in the ED: a Retrospective Study
NCT05864378
A Bedside Portable Endoscopy for the Esophageal Foreign Body
NCT03009383
EUS - Guided Balloon-occluded Gastrojejunostomy Bypass
NCT03223480
Diagnostic Performance of Point of Care Ultrasound to Identify Intestinal Obstruction
NCT04848415
Pilot Study for Imaging of the Esophagus Using a Tethered Capsule OCT Endomicroscopy in the Primary Care Setting
NCT02445027
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Esophageal foreign body/impaction (suspected)
Point of care ultrasound
Point of care medical ultrasound machines will be used to sonographically visualize the esophagus and following sonographic data will be collected:
* Presence/absence of suspected foreign body
* Sonographic esophageal measurements (diameters, area)
* Other relevant secondary sonographic findings
Control (No symptoms of esophageal foreign body/impaction)
Point of care ultrasound
Point of care medical ultrasound machines will be used to sonographically visualize the esophagus and following sonographic data will be collected:
* Presence/absence of suspected foreign body
* Sonographic esophageal measurements (diameters, area)
* Other relevant secondary sonographic findings
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Point of care ultrasound
Point of care medical ultrasound machines will be used to sonographically visualize the esophagus and following sonographic data will be collected:
* Presence/absence of suspected foreign body
* Sonographic esophageal measurements (diameters, area)
* Other relevant secondary sonographic findings
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Signs and symptoms of esophageal food bolus or foreign body
1. Age ≥18 years
2. NO signs or symptoms of esophageal food bolus or foreign body
3. Age/Sex match to previously enrolled case subject
Exclusion Criteria
2. History of head/neck cancer
3. Incarcerated individuals
4. Individuals unable to provide consent
5. Clinical instability or airway compromise
Eligibility (CONTROLS)
1. Prior esophageal surgery/dilation/pathology
2. History of head/neck cancer
3. Incarcerated individuals
4. Individuals unable to provide consent
5. Clinical instability or airway compromise
6. Presentation involving any of the following symptoms:
* Nausea/vomiting
* Diarrhea
* Abdominal pain
* Chest pain
* Shortness of breath
* Dysphagia/odynophagia
* Cough
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
WellSpan Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brent Becker
Research Director - Department of Emergency Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
WellSpan Health York Hospital
York, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2207289
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.